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Case description of a male patient of 64 years who presents a left groin-scrotum painless tumor, growing,
from several months of evolution. Physical examination demonstrated the existence of a mass effect of
the left distal spermatic cord, and was later conﬁrmed by ultrasound and CT. Laboratory parameters were
normal. The performed surgery consisted in a radical orchiectomy with high ligation of the left cord. In
conclusion, preoperative diagnosis of spermatic cord leiomyosarcoma is difﬁcult we need the combi-
nation of present illness, physical examination, exams and the gold standard histopathological and
immunohistochemical studies allowed a deﬁnitive diagnosis.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Paratesticular tumors, those in relation to the testicle, are
uncommon malignant neoplasms. Only 7% have paratesticular
location. They can be divided into liquid and solid. These e at the
same time e are divided into benign and malignant. Sarcomas
make up 90% of the total, and within these, leiomyosarcoma
represents approximately 10% overall of histopathologic varieties
described in the literature.
Clinical case
G.C.C., Mexican, of 64 years old. Began suffering his condition
8e9 months ago with increasing volume of the left groin-scrotum.
Physical examination shows a well-delimited mass, seems to
form body with the spermatic cord, it is mobile, of irregular surface,
of hard-elastic consistency, discreetly painful to pressure, appar-
ently respects the testicle and epididymis and is negative to
contrast lightning. Another mass is founded in the superﬁcial
inguinal region. The general analytical determinations in blood and
urine were normal. The serum levels of alpha-fetoprotein and beta-
hCG resulted at the same time within normal limits. An ultrasound
shows evidence of a mass of 1510 cm in the groin-scrotum regionardines del Valle, C.P.25260
þ52 8444159285.
igerio).
Inc. This is an open access article uand adenopathy of 5 cm diameter in the left groin. A CT scan was
performed and the markers for germ injuries came out negative. A
biopsy is performed with a thick needle and considering an aden-
opathy, it suggests a mesothelial injury and it is identiﬁed as a
leiomyosarcoma of spermatic condom.
It was proposed to proceed with a surgical exploration that took
place on 04/16/2014 and whose protocol informs: left groin-
scrotum incision, previously repairing the vascular elements of
the cord, proceed to explore the tumor.
This is presented above the gonad, of whitish color and with
invasive nature, but rejects to include the nervous and vascular
elements in the process. The intraoperative biopsy of the tumor
showed sarcomata’s tissue with fusiform cell. The result of the ﬁnal
histopathology together with the immunohistochemically positiv-
ity for the speciﬁc smooth-muscle actin, allowed to establish the
ﬁnal diagnosis of well differentiated paratesticular leiomyosarcoma
distinct without vascular invasion, but with epididymal inﬁltration.
We proceed to the radical orchiectomy with high ligation of the
spermatic cord. Scrotal drainage by counteropening and closure by
levels. Tumor-free surgical limits. The postoperative evolution was
satisfactory.Histopathology report
Malignant neoformation of mesenchymal origin with smooth-
muscle differentiation constituted by interwoven fascicles of cells
with eosinophilic cytoplasm and fusiform core with areas of
abundant mitosis (10e12 mitosis/10 increase ﬁelds).nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 2. Surgical specimen. Presented above the gonad, of whitish color and with
invasive nature.
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Paratesticular primitive tumors can be divided, according to
their location in: tumors in testicular tunics, epididymis and
spermatic cord. The ﬁrst case of sarcoma of the spermatic cord
was contributed by Lesauvage in 1845. Spermatic cord tumors are
the most common comprising approximately 75%, being 90% of
them of mesodermal origin. The most common neoplasms are
those of benign strain (70%), most of them being lipomas.
Furthermore, due to the embryologic mesodermal origin of the
spermatic cord as from the Wolf conduit, most malignant tumors
are from sarcomatous lineage and include rhabdomyosarcoma,
leiomyosarcoma, liposarcoma, malignant ﬁbrous histiocytoma and
ﬁbrosarcomas.
The cases of spermatic cord leiomyosarcoma collected in the
literature allow to appreciate a higher incidence in adulthood as
from the sixth decade of life. Intimate pathophysiologic mecha-
nisms that lead to the occurrence of these neoplasms are unknown,
although it is speculated with the role that could play an occasional
degeneration of a leiomyoma originated prior from funicular
structures constructed by smooth-muscle.1,2
The preoperative diagnosis between paratesticular and testic-
ular tumor is complex, but it can sometimes be clinically elucidated
when it comes to a small cord tumor that is palpable independently
to the testicle. However larger paratesticular tumors are more
difﬁcult to diagnose by simple exploration and we must support
ourselves in radiological tests such as ultrasound, CT or MRI. These
diagnostic methods will help us differentiate whether the tumors
are dependent, or not, to the testicle, and specially they will direct
us toward the type of tumor histology (Figs. 1e3).
While benign cases can be seen as a well-delimited, homoge-
neous and hypoechoic image on the ultrasound, the malignant
neoplasms of said region are usually displayed as a solid mass,
vascularized, hyperechoic and heterogeneous with necrosis areas
and variable size which tends to move the testicle.
The deﬁnitive diagnosis is given by pathologic examination.
While the immunohistochemical techniques facilitate the diag-
nosis, they may sometimes not be conclusive. The speciﬁc muscle
actin must be positive, as well as the Desmin and not the Vimentin
or S 100 Protein, found infat cells.3,4
From the pathological point of view, it is accepted as a poor
prognosis: 1) high cellularity, 2) vascular invasion, 3) necrotic areas,
4) presence of multinucleated cells and 5) mitotic index greater
than 2.5Figure 1. Radical orchiectomy with high ligation of the spermatic cord. Scrotal
drainage by counteropening and closure by levels. Tumor-free surgical limits.As deﬁnitive treatment, inguinal radical orchiectomy with high
ligation of the spermatic cord is accepted. There is no uniformity of
criteria at the moment to indicate adjuvant therapy, given the short
experience in his treatment. While some authors advocate the
prophylactic irradiation even after primary surgery for local disease
control and even reduce local recurrence, others do not believe it
has the role of controlling local recurrences.5 Proponents adjuvant
radiotherapy propose it in the inguinal canal and adjacent pelvic
tissue. The retroperitoneal lymphadenectomy is reserved for cases
for rhabdomyosarcoma histopathological diagnosis and of cases ofFigure 3. The intraoperative biopsy of the tumor showed sarcomata’s tissue with
fusiform cell. The result of the ﬁnal histopathology together with the immunohis-
tochemically positivity for the speciﬁc smooth-muscle actin, allowed to establish the
ﬁnal diagnosis of well differentiated para-testicular leiomyosarcoma distinct without
vascular invasion, but with epididymal inﬁltration.
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made hematogenously, so that prophylactic irradiation lacks of
indication nowadays.4
Conclusion
In conclusion, spermatic cord sarcomas constitute a rare entity
that usually debuts as an indolent paratesticular mass. Radiological
methods such as ultrasound, CT or MRI are needed for its diagnose,
radical orchiectomy and the excision of cord elements are accepted
as treatment. The spread can be both lymphatic and hematogenous
mostly to liver and lung. Retroperitoneal lymph node dissection is
not recommended as prophylactic, and compared to surgery, the
effects of adjuvant therapies, including chemotherapy and radiation
therapy are unknown, although many authors recommend it
following radical surgery.Conﬂict of interest
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